Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral Nerve Blocks for Major Lower Extremity Amputations
NCT03174782Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- Jan 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Postoperative Pain at 6 months. Started Jan 2018; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03174782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174782.